Nephros Inc - Asset Resilience Ratio
Nephros Inc (NEPH) has an Asset Resilience Ratio of 0.56% as of March 2018. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Check strategic asset allocation of Nephros Inc to assess the company's strategic physical and investment asset allocation.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2004–2018)
This chart shows how Nephros Inc's Asset Resilience Ratio has changed over time. See debt-free asset ratio of Nephros Inc to measure how much of total assets are equity-financed.
Liquid Assets Composition Over Time
This chart breaks down Nephros Inc's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see NEPH stock market capitalisation.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 0% |
| Short-term Investments | $26.00K | 0.56% |
| Total Liquid Assets | $26.00K | 0.56% |
Asset Resilience Insights
- Limited Liquidity: Nephros Inc maintains only 0.56% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
Nephros Inc Industry Peers by Asset Resilience Ratio
Compare Nephros Inc's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
QITIAN Technology Group Co Ltd
SHE:300061 |
Medical Instruments & Supplies | 0.00% |
|
Visco Vision Inc.
TW:6782 |
Medical Instruments & Supplies | 0.98% |
|
Daxor Corporation
NASDAQ:DXR |
Medical Instruments & Supplies | 65.10% |
|
GETS Global Bhd
KLSE:5079 |
Medical Instruments & Supplies | 0.03% |
|
Osteopore Ltd
AU:OSX |
Medical Instruments & Supplies | 22.60% |
|
Safe Orthopaedics SA
PA:ALSAF |
Medical Instruments & Supplies | 2.20% |
|
Ansell Ltd
AU:ANN |
Medical Instruments & Supplies | 7.53% |
|
Nanosonics Ltd
AU:NAN |
Medical Instruments & Supplies | 46.84% |
Annual Asset Resilience Ratio for Nephros Inc (2004–2018)
The table below shows the annual Asset Resilience Ratio data for Nephros Inc.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2018-12-31 | 0.00% | $0.00 | $10.56 Million | -- |
| 2017-12-31 | 0.40% | $20.00K | $4.98 Million | -0.61pp |
| 2016-12-31 | 1.01% | $27.00K | $2.68 Million | +0.83pp |
| 2008-12-31 | 0.17% | $7.00K | $4.04 Million | -46.43pp |
| 2007-12-31 | 46.60% | $4.70 Million | $10.09 Million | -7.59pp |
| 2006-12-31 | 54.19% | $2.80 Million | $5.17 Million | -3.32pp |
| 2005-12-31 | 57.51% | $4.50 Million | $7.82 Million | +8.39pp |
| 2004-12-31 | 49.12% | $6.00 Million | $12.21 Million | -- |
About Nephros Inc
Nephros, Inc., a commercial-stage company, develops and sells water filtration solutions for medical and commercial applications in the United States. It offers ultrafiltration products that are used in dialysis centers for the removal of biological contaminants from water and bicarbonate concentrate; and in hospitals for the prevention of infection from waterborne pathogens, such as legionella a… Read more